Adore Beauty Group Limited
ASX:ABY.AX
0.97 (AUD) • At close November 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 95.048 | 100.671 | 87.012 | 93.576 | 86.557 | 113.103 | 83.114 | 96.163 | 69.142 | 52 |
| Cost of Revenue
| 75.279 | 78.687 | 68.748 | 73.332 | 67.718 | 87.299 | 64.867 | 74.877 | 52.283 | 41.3 |
| Gross Profit
| 19.769 | 21.984 | 18.264 | 20.244 | 18.839 | 25.804 | 18.247 | 21.286 | 16.859 | 10.7 |
| Gross Profit Ratio
| 0.208 | 0.218 | 0.21 | 0.216 | 0.218 | 0.228 | 0.22 | 0.221 | 0.244 | 0.206 |
| Reseach & Development Expenses
| 0 | 0 | 0.002 | 0 | 0.002 | 0 | 0.001 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 6.817 | 6.457 | 6.882 | 5.63 | 7.123 | 5.337 | 5.651 | 6.989 | 3.682 |
| Selling & Marketing Expenses
| 0 | 13.934 | 12.647 | 14.108 | 12.315 | 15.889 | 11.179 | 11.894 | 8.306 | 5.718 |
| SG&A
| 18.712 | 20.751 | 19.104 | 20.92 | 17.945 | 23.012 | 16.516 | 17.545 | 15.295 | 9.4 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 18.712 | 20.751 | 19.104 | 20.92 | 17.945 | 23.012 | 16.516 | 17.545 | 15.295 | 9.4 |
| Operating Income
| 1.057 | 1.233 | -0.84 | -0.676 | 0.894 | 2.792 | 1.731 | 3.741 | 1.564 | 1.3 |
| Operating Income Ratio
| 0.011 | 0.012 | -0.01 | -0.007 | 0.01 | 0.025 | 0.021 | 0.039 | 0.023 | 0.025 |
| Total Other Income Expenses Net
| 0.266 | 0.269 | 0.118 | -0.053 | -0.363 | -0.016 | -0.161 | -5.265 | -1.865 | -0.1 |
| Income Before Tax
| 1.323 | 1.502 | -0.722 | -0.729 | 0.531 | 2.776 | 1.57 | -1.524 | -0.302 | 1.2 |
| Income Before Tax Ratio
| 0.014 | 0.015 | -0.008 | -0.008 | 0.006 | 0.025 | 0.019 | -0.016 | -0.004 | 0.023 |
| Income Tax Expense
| 0.14 | 0.51 | -0.253 | -0.639 | 0.121 | 0.809 | 3.261 | -4.06 | 1.827 | 0.4 |
| Net Income
| 1.183 | 0.992 | -0.469 | -0.09 | 0.41 | 1.967 | -1.691 | 2.536 | -2.129 | 0.9 |
| Net Income Ratio
| 0.012 | 0.01 | -0.005 | -0.001 | 0.005 | 0.017 | -0.02 | 0.026 | -0.031 | 0.017 |
| EPS
| 0.013 | 0.011 | -0.005 | -0.001 | 0.004 | 0.021 | -0.018 | 0.027 | -0.023 | 0.01 |
| EPS Diluted
| 0.012 | 0.01 | -0.005 | -0.001 | 0.004 | 0.021 | -0.018 | 0.027 | -0.023 | 0.01 |
| EBITDA
| 2.768 | 2.354 | 0.477 | 0.406 | 1.659 | 3.704 | 2.436 | -0.764 | 2.154 | 1.9 |
| EBITDA Ratio
| 0.029 | 0.023 | 0.003 | 0.004 | 0.021 | 0.033 | 0.03 | 0.046 | 0.031 | 0.037 |